How should McArdle disease (glycogen storage disease type V) be diagnosed and managed?

McArdle Disease (Glycogen Storage Disease Type V): Diagnosis and Management

Diagnosis

McArdle disease should be suspected in any patient presenting with exercise intolerance, muscle pain, and elevated creatine kinase (CK), and confirmed through genetic testing of the PYGM gene. 1, 2

Clinical Presentation

The hallmark features to recognize include:

• Exercise intolerance (100% of cases) - particularly severe pain occurring early after onset of physical activity 1, 2
• Muscle pain and cramping (75%) - typically triggered by brief, intense exercise rather than sustained moderate activity 1, 3
• "Second wind" phenomenon (62.5%) - improvement in exercise tolerance after 8-10 minutes of continued activity, a pathognomonic feature 1, 3
• Myoglobinuria and rhabdomyolysis - often precipitated by eccentric, unpredicted activities rather than regular structured exercise 3, 4
• Symptom onset in childhood - median age 5.5 years, though diagnosis is typically delayed until adulthood (median 9.5 years to diagnosis) 3, 4

Key Diagnostic Pitfall

McArdle disease is severely underdiagnosed, with diagnostic delays averaging 29 years from symptom onset. 3, 4 Over 90% of cases are diagnosed late, with more than 50% not diagnosed until adulthood despite preschool symptom onset. This occurs because symptoms are commonly misattributed to poor physical fitness, viral myositis, or other neuromuscular disorders 1, 5, 6.

Laboratory Findings

• Markedly elevated CK levels - often >50,000 IU/L during rhabdomyolysis episodes, but may be persistently elevated even at baseline (>1,000-1,500 IU/L) 1, 3, 6
• Myoglobinuria during acute episodes
• Normal metabolic parameters - unlike GSD types I and III, there is no hypoglycemia, hepatomegaly, or metabolic acidosis under normal circumstances 7

Diagnostic Testing Algorithm

1. Genetic testing is the gold standard - sequence the PYGM gene for pathogenic variants 1, 2, 3

   • The c.148C>T (p.Arg50*) variant is the most common mutation 3, 4
   • This variant shows a genotype-phenotype correlation: homozygosity is associated with increased myoglobinuria and higher CK elevation in a dosage-dependent manner 4

2. Non-ischemic forearm exercise test - can be performed but is less commonly used in pediatric practice 3

3. Muscle biopsy - shows glycogen accumulation in subsarcolemmal vacuoles and absent myophosphorylase activity, but genetic testing has largely replaced this invasive procedure 2, 3

Distinguishing from Other GSDs

Unlike GSD III (which the provided guidelines primarily address), McArdle disease has:

• No hepatomegaly or hypoglycemia 7
• Dynamic symptoms of exertional muscle contractures - a key distinguishing feature 7
• Rhabdomyolysis with brief intense exercise rather than the chronic progressive weakness seen in GSD III 7
• No respiratory muscle involvement - unlike Pompe disease (GSD II) 7

Management

Management centers on structured exercise training to identify and utilize the "second wind" phenomenon, combined with pre-exercise carbohydrate supplementation. 3, 8

Exercise Management

• Structured exercise testing with a multidisciplinary team to help patients identify their "second wind" threshold 3
• Regular moderate aerobic exercise is beneficial and should be encouraged, similar to recommendations for GSD V 7
• Avoid maximal effort and eccentric activities - these trigger rhabdomyolysis more readily than sustained moderate exercise 3, 8
• Warm-up period of 8-10 minutes allows the second wind phenomenon to develop, improving exercise tolerance 1, 3

Nutritional Interventions

• 25g maltodextrin before structured exercise - statistically significant effect on ameliorating ratings of perceived exertion 3
• Simple carbohydrate intake before and during exercise can improve symptoms 1, 3
• Caution with excessive carbohydrate use - may lead to weight gain 3

Important Caveats

Avoid succinylcholine and other depolarizing agents during anesthesia - these can precipitate rhabdomyolysis in patients with myopathy 7. While this recommendation comes from GSD III guidelines, it applies equally to all metabolic myopathies including McArdle disease.

Monitoring

• CK levels - track baseline and during acute episodes
• Renal function - during rhabdomyolysis episodes, as acute renal failure can occur 2
• Exercise tolerance and quality of life - through structured assessments 3, 8

Genetic Counseling

All patients and families should receive genetic counseling given the autosomal recessive inheritance pattern 1, 2. Family screening is essential, as siblings may have similar symptoms but remain undiagnosed. This enables informed reproductive planning and early intervention for affected family members 1.

Prognosis and Quality of Life

Early recognition and tailored management substantially improve quality of life. 1, 3 Simple measures including regular moderate exercise, carbohydrate supplementation, and education about activity modification can dramatically improve daily functioning. Early intervention and education in childhood may improve outcomes into adult life 3.